Norris ORIEN Total Cancer Care
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Southern California
About this trial
This research trial collects biological samples and clinical information to create a repository of data from patients with cancer or a predisposition for cancer. Combining genetic information from biological samples and clinical data may lead to more knowledge about why certain cancers respond to treatment and help create more personalized medicine.
Eligibility criteria
Qualifiers
Limited to those patients who are registered for outpatient or inpatient care at University of Southern California (USC) Norris
Able to understand and sign the TCCP informed consent, California subject's bill of rights, Health Insurance Portability and Accountability Act (HIPAA), and research authorization form directly or through an authorized representative; the informed consent, subject's bill of rights, HIPAA, and research authorization will be available in both English and Spanish languages
Disqualifiers
Individuals who are not registered as patients for outpatient or inpatient care at USC Norris
Individuals who are unable to understand or sign the TCCP informed consent, subject's bill of rights, HIPAA, and research authorization in either English or Spanish
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Evaluation of Cancer Risk Factors
- Medical Chart Review
- Quality-of-Life Assessment
- Questionnaire Administration
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov